New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal Neuroimmunology & Neuroinflammation on April 26, 2022, titled "Heterogeneity of Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Patients With Myasthenia Gravis."

Read the paper here: https://nn.neurology.org/content/9/4/e1169

Learn more about MGNet: https://www.rarediseasesnetwork.org/mgnet